Literature DB >> 12180235

Role of Oxalobacter formigenes in calcium oxalate stone disease: a study from North India.

R Kumar1, M Mukherjee, M Bhandari, A Kumar, H Sidhu, R D Mittal.   

Abstract

OBJECTIVE: The present study was performed to detect the presence of an oxalate degrading bacteria Oxalobacter formigenes in the GI tract of calcium oxalate stone patients and normal individuals from North India. Furthermore, the possible relationship of this bacterium with number of stone episodes in this part of the world was also studied. The correlation of the presence or absence of O. formigenes with the urinary oxalate levels was evaluated.
METHODS: DNA was extracted from the stool samples of 63 calcium oxalate stone formers and 40 normal individuals. Polymerase chain reaction (PCR) was performed using genus specific primers for O. formigenes. The presence of which was confirmed by Southern blotting. Urinary oxalate levels were tested in each patient.
RESULTS: As shown by PCR and Southern blotting, O. formigenes was present in 65% of normal individuals and in 30% of calcium oxalate stone formers. In patients with three or greater than three stone episodes colonies were present only in 5.6% of patients. Oxalate excretion was less in patients colonized with O. formigenes as compared to those with no colonization.
CONCLUSION: In North Indian population the absence of O. formigenes can lead to a significant increase in the risk of absorptive hyperoxaluria and resultant recurrent calcium oxalate stone episodes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12180235     DOI: 10.1016/s0302-2838(02)00040-4

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  24 in total

1.  Inhibition of urinary stone disease by a multi-species bacterial network ensures healthy oxalate homeostasis.

Authors:  Aaron W Miller; David Choy; Kristina L Penniston; Dirk Lange
Journal:  Kidney Int       Date:  2019-02-28       Impact factor: 10.612

Review 2.  Intestinal transport of an obdurate anion: oxalate.

Authors:  Marguerite Hatch; Robert W Freel
Journal:  Urol Res       Date:  2004-11-25

Review 3.  The roles and mechanisms of intestinal oxalate transport in oxalate homeostasis.

Authors:  Marguerite Hatch; Robert W Freel
Journal:  Semin Nephrol       Date:  2008-03       Impact factor: 5.299

4.  Oral antibiotic treatment of Helicobacter pylori leads to persistently reduced intestinal colonization rates with Oxalobacter formigenes.

Authors:  Viktoria Kharlamb; Jennifer Schelker; Fritz Francois; Juquan Jiang; Ross P Holmes; David S Goldfarb
Journal:  J Endourol       Date:  2011-10-21       Impact factor: 2.942

5.  Genetically engineered Lactobacillus plantarum WCFS1 constitutively secreting heterologous oxalate decarboxylase and degrading oxalate under in vitro.

Authors:  Ponnusamy Sasikumar; Sivasamy Gomathi; Kolandaswamy Anbazhagan; A Ebenezer Baby; J Sangeetha; Govindan Sadasivam Selvam
Journal:  Curr Microbiol       Date:  2014-07-03       Impact factor: 2.188

6.  Enteric hyperoxaluria, recurrent urolithiasis, and systemic oxalosis in patients with Crohn's disease.

Authors:  Renate Hueppelshaeuser; Gerd E von Unruh; Sandra Habbig; Bodo B Beck; Stephan Buderus; Albrecht Hesse; Bernd Hoppe
Journal:  Pediatr Nephrol       Date:  2012-02-25       Impact factor: 3.714

7.  Gut microbiota and oxalate homeostasis.

Authors:  Marguerite Hatch
Journal:  Ann Transl Med       Date:  2017-01

8.  Oxalobacter formigenes reduce the risk of kidney stones in patients exposed to oral antibiotics: a case-control study.

Authors:  Yamuna Ravikumar; Rukaiah Fatma Begum; Ramaiyan Velmurugan
Journal:  Int Urol Nephrol       Date:  2020-09-02       Impact factor: 2.370

Review 9.  The use of antibiotics and risk of kidney stones.

Authors:  Shivam Joshi; David S Goldfarb
Journal:  Curr Opin Nephrol Hypertens       Date:  2019-07       Impact factor: 2.894

Review 10.  History, epidemiology and regional diversities of urolithiasis.

Authors:  Michelle López; Bernd Hoppe
Journal:  Pediatr Nephrol       Date:  2010-01       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.